- Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019
-
Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH
- KMID: 2529664
- Korean J Intern Med.
- 2022 May;37(3):673-680.
- doi: 10.3904/kjim.2020.633
Background/Aims: The preventive role of hydroxychloroquine (HCQ) on coronavirus disease 2019 (COVID-19) remains unclear. The aim of this study was to examine the effects of HCQ and other immunosuppressive drugs... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
-
Singh A, Kotlo A, Wang Z, Dissanayaka T, Das S, Antony B
- KMID: 2524256
- Korean J Intern Med.
- 2022 Jan;37(1):210-221.
- doi: 10.3904/kjim.2020.605
Background/Aims: Conventional disease-modifying anti-rheumatic drugs have been trialed in osteoarthritis (OA). Hydroxychloroquine (HCQ), which has shown its effectiveness in rheumatoid arthritis, has been trialed for the treatment of OA; however,... -
- CITED
-
- Close
- SHARE
-
- Close
- Amphiphilic Myopathy Induced by Hydroxychloroquine Presenting with Dysarthria
-
Sung E, Kim H, Lee H, Lee S
- KMID: 2523955
- Korean J Neuromuscul Disord.
- 2021 Dec;13(2):52-54.
- doi: 10.46518/kjnmd.2021.13.2.52
Chloroquine and hydroxychloroquine (HCQ) are commonly used antimalarial agents as the treatment for a wide range of autoimmune disorders including dermatological, rheumatoid, and connective tissue diseases. These amphiphilic drugs can... -
- CITED
-
- Close
- SHARE
-
- Close
- Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
-
Kim JW, Kim EJ, Kwon HH, Jung CY, Kim KC, Choe JY, Hong HL
- KMID: 2513833
- Korean J Intern Med.
- 2021 Mar;36(Suppl 1):S253-S263.
- doi: 10.3904/kjim.2020.224
Background/Aims: The efficacies of lopinavir-ritonavir or hydroxychloroquine remain to be determined in patients with coronavirus disease 2019 (COVID-19). To compare the virological and clinical responses to lopinavir-ritonavir and hydroxychloroquine treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Evolution of COVID-19 management in critical care: review and perspective from a hospital in the United Kingdom
-
Jha AK, Kulkarni SG
- KMID: 2513248
- Acute Crit Care.
- 2021 Feb;36(1):1-14.
- doi: 10.4266/acc.2020.00864
The unexpected emergence and spread of coronavirus disease 2019 (COVID-19) has been pandemic, with long-lasting effects, and unfortunately, it does not seem to have ended. Integrating advanced planning, strong teamwork,... -
- CITED
-
- Close
- SHARE
-
- Close
- Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
-
Fernando EZ, Yu JRT, Santos SMA, Jamora RDG
- KMID: 2511492
- J Mov Disord.
- 2021 Jan;14(1):75-77.
- doi: 10.14802/jmd.20091
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
-
Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee W, Ahn JH
- KMID: 2507534
- Infect Chemother.
- 2020 Sep;52(3):396-402.
- doi: 10.3947/ic.2020.52.3.396
There are no proven therapeutics for Coronavirus disease 2019 (COVID-19) pneumonia outbreak. We observed and analyzed the clinical efficacy of the most used hydroxychloroquine (HCQ) for 30 days. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
-
Kang CK, Seong MW, Choi SJ, Kim TS, Choe PG, Song SH, Kim NJ, Park WB, Oh Md
- KMID: 2504168
- Korean J Intern Med.
- 2020 Jul;35(4):782-787.
- doi: 10.3904/kjim.2020.157
Background/Aims: As the coronavirus disease-2019 global pandemic progresses, screening of antiviral agents effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is urgently needed. In addition, considering the viral load... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
-
Ahn BY, Kang CK, Seo JD, Choe PG, Song SH, Park WB, Park SW, Kim NJ, Oh Md
- KMID: 2503019
- J Korean Med Sci.
- 2020 Jun;35(24):e231.
- doi: 10.3346/jkms.2020.35.e231
There have been controversies on the prophylactic effect of hydroxychloroquine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We describe a patient, 60-year old Korean woman, with coronavirus disease 2019 (COVID-19)... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-malarial Drugs Reduce Vascular Smooth Muscle Cell Proliferation via Activation of AMPK and Inhibition of Smad3 Signaling
-
Lee H, Han JH, Kim S, Kim S, Cho DH, Woo CH
- KMID: 2458392
- J Lipid Atheroscler.
- 2019 Sep;8(2):267-276.
- doi: 10.12997/jla.2019.8.2.267
OBJECTIVE: The aim of this study was to investigate the effects of 2 anti-malarial drugs, chloroquine (CQ) and hydroxychloroquine (HCQ), on inhibition of vascular smooth muscle cell (VSMC) proliferation both... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and validation of LC-MS/MS for bioanalysis of hydroxychloroquine in human whole blood
-
Park JY, Song HH, Kwon YE, Kim SJ, Jang S, Joo SS
- KMID: 2435750
- J Biomed Transl Res.
- 2018 Dec;19(4):130-139.
- doi: 10.12729/jbtr.2018.19.4.130
This study aimed to analyze a high-performance liquid chromatography (HPLC) separation using a pentafluorophenyl column of parent drug hydroxychloroquine (HCQ) and its active metabolite, desethylhydroxchloroquine (DHCQ) applying to determine bioequivalence... -
- CITED
-
- Close
- SHARE
-
- Close
- Peripapillary Retinal Nerve Fiber Layer Thicknesses Did Not Change in Long-term Hydroxychloroquine Users
-
Lee EJ, Kim SJ, Han JC, Eo DR, Lee MG, Ham DI, Kang SW, Kee C, Lee J, Cha HS, Koh EM
- KMID: 2427960
- Korean J Ophthalmol.
- 2018 Dec;32(6):459-469.
- doi: 10.3341/kjo.2018.0004
PURPOSE: To evaluate changes in the peripapillary retinal nerve fiber layer (RNFL) thicknesses using spectral-domain optical coherence tomography (SD-OCT) in hydroxychloroquine (HCQ) users. METHODS: The medical records of HCQ users were... -
- CITED
-
- Close
- SHARE
-
- Close
- Hydroxychloroquine Retinopathy Update
-
Ahn SJ, Lee BR
- KMID: 2415603
- J Rheum Dis.
- 2018 Jul;25(3):153-157.
- doi: 10.4078/jrd.2018.25.3.153
Hydroxychloroquine (HCQ) has been used widely for the treatment of several rheumatologic and dermatologic conditions, including systemic lupus erythematosus and rheumatoid arthritis. Its toxic effects on the retina, HCQ retinopathy,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Recurrent Steroid-dependent Kikuchi-Fujimoto Disease Successfully Treated with Hydroxychloroquine
-
Jang KM, Lee JM
- KMID: 2396017
- Clin Pediatr Hematol Oncol.
- 2017 Oct;24(2):144-147.
- doi: 10.15264/cpho.2017.24.2.144
Kikuchi-Fujimoto disease (KFD) is known as a self-limiting disease. The most common symptoms include fever, cervical lymphadenopathy, and pain, but nonspecific symptoms such as joint pain, nausea, chills, diaphoresis, and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Treatment with Steroid and Hydrochloroquine of Thrombocytopenia in Primary Sjögren's Syndrome
-
Yun YS, Choi JW, Doo YJ, Kim TH, Oh HL, Oh JM
- KMID: 2384841
- Kosin Med J.
- 2017 Jun;32(1):118-126.
- doi: 10.7180/kmj.2017.32.1.118
Sjögren's syndrome is a systemic autoimmune disease characterized by sicca symptoms and extraglandular manifestations. Anemia, leukopenia, thrombocytopenia and lymphoproliferative disorders are well-known extraglandular, hematological complications of Sjögren's syndrome. These hematologic... -
- CITED
-
- Close
- SHARE
-
- Close
- Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases
-
Eo DR, Lee MG, Ham DI, Kang SW, Lee J, Cha HS, Koh E, Kim SJ
- KMID: 2366651
- J Korean Med Sci.
- 2017 Mar;32(3):522-527.
- doi: 10.3346/jkms.2017.32.3.522
This study aimed to evaluate the frequency and clinical characteristics of hydroxychloroquine (HCQ) retinopathy in Korean patients with rheumatologic diseases. We retrospectively reviewed medical records of 310 patients taking HCQ.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study
-
Yoon CH, Lee HJ, Lee EY, Lee EB, Lee WW, Kim MK, Wee WR
- KMID: 2373734
- J Korean Med Sci.
- 2016 Jul;31(7):1127-1135.
- doi: 10.3346/jkms.2016.31.7.1127
The effect of hydroxychloroquine (HCQ) on dry eye has not been fully determined. This study aimed to compare the 12-week efficacy of HCQ medication with that of a placebo in... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrent Kikuchi's Disease Treated by Hydroxychloroquine
-
Hyun M, So IT, Kim HA, Jung H, Ryu SY
- KMID: 2327980
- Infect Chemother.
- 2016 Jun;48(2):127-131.
- doi: 10.3947/ic.2016.48.2.127
Kikuchi-Fujimoto disease (KFD) is a benign, self-limiting disease, with a specific histopathology. It can be diagnosed clinically, and specific symptoms include fever and cervical lymphadenopathy. The histological finding of KFD... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Hydroxychloroquine-Induced Recalcitrant Acute Generalized Exanthematous Pustulosis with Cyclosporine: Case Report and Literature Review
-
Yalcin B, Cakmak S, Yildirim B
- KMID: 2171501
- Ann Dermatol.
- 2015 Aug;27(4):431-434.
- doi: 10.5021/ad.2015.27.4.431
Acute generalized exanthematous pustulosis (AGEP) is a cutaneous reaction principally induced by drugs. Spontaneous resolution is observed in most patients. However, severe cases required systemic corticosteroid administration. Hydroxychloroquine, which is... -
- CITED
-
- Close
- SHARE
-
- Close
- Hydroxychloroquine Retinopathy
-
Lee J, Lee JY
- KMID: 2222879
- J Rheum Dis.
- 2015 Jun;22(3):140-145.
- doi: 10.4078/jrd.2015.22.3.140
Hydroxychloroquine (HCQ) has been widely used for treatment of various rheumatic and dermatologic diseases. However, under a high cumulative dose, HCQ may cause retinal toxicity. In this review, we summarize... -
- CITED
-
- Close
- SHARE
-
- Close
